Ralph Lauren Corporation (RL) Stock Forecast
Data as of May 2, 2026Consumer Cyclical · Current price $363.54 (+1.37%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 6, 2026 | Bob Drbul | BTIG | $435.00 | +19.7% |
| Feb 6, 2026 | Paul Kearney | Barclays | $416.00 | +14.4% |
| Jan 8, 2026 | Krisztina Katai | Deutsche Bank | $422.00 | +16.1% |
| Dec 3, 2025 | Ike Boruchow | Wells Fargo | $385.00 | +5.9% |
| Sep 17, 2025 | Dana Telsey | Telsey Advisory | $350.00 | -3.7% |
| May 23, 2025 | Ike Boruchow | Wells Fargo | $300.00 | -17.5% |
| May 23, 2025 | Jay Sole | UBS | $384.00 | +5.6% |
| May 14, 2025 | Ike Boruchow | Wells Fargo | $275.00 | -24.4% |
| Apr 28, 2025 | Paul Kearney | Barclays | $260.00 | -28.5% |
| Jan 10, 2025 | Jay Sole | UBS | $315.00 | -13.4% |
| Nov 8, 2024 | Dana Telsey | Telsey Advisory | $247.00 | -32.1% |
| Oct 29, 2024 | Paul Lejuez | Citigroup | $189.00 | -48.0% |
| Oct 23, 2024 | Ike Boruchow | Wells Fargo | $205.00 | -43.6% |
| Oct 17, 2024 | Zachary Warring | CFRA | $171.00 | -53.0% |
| Aug 8, 2024 | Paul Kearney | Barclays | $200.00 | -45.0% |
| May 24, 2024 | Rick Patel | Raymond James | $195.00 | -46.4% |
| May 24, 2024 | Ike Boruchow | Wells Fargo | $180.00 | -50.5% |
| May 23, 2024 | Zachary Warring | CFRA | $160.00 | -56.0% |
| May 23, 2024 | Simeon Siegel | BMO Capital | $113.00 | -68.9% |
| May 16, 2024 | Jay Sole | UBS | $250.00 | -31.2% |
Top Analysts Covering RL
RL vs Sector & Market
| Metric | RL | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.05 | 2.53 | 2.41 |
| Analyst Count | 22 | 13 | 18 |
| Target Upside | +17.9% | +417.4% | +14.9% |
| P/E Ratio | 24.75 | 11.23 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-27 | $1.83B | $1.84B | $1.86B | 7 |
| 2026-09-27 | $2.10B | $2.12B | $2.15B | 3 |
| 2026-12-27 | $2.52B | $2.54B | $2.58B | 3 |
| 2027-03-27 | $1.92B | $1.94B | $1.97B | 3 |
| 2027-03-29 | $8.35B | $8.44B | $8.66B | 13 |
| 2027-06-27 | $1.88B | $1.89B | $1.92B | 6 |
| 2027-09-27 | $2.10B | $2.12B | $2.15B | 5 |
| 2027-12-27 | $2.51B | $2.54B | $2.57B | 4 |
| 2028-03-27 | $1.95B | $1.97B | $2.00B | 3 |
| 2028-03-29 | $8.78B | $8.81B | $8.83B | 14 |
| 2029-03-29 | $9.22B | $9.38B | $9.54B | 1 |
| 2030-03-29 | $9.74B | $9.86B | $10.07B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-27 | $3.86 | $4.09 | $4.27 | 9 |
| 2026-09-27 | $3.91 | $3.96 | $4.04 | 3 |
| 2026-12-27 | $6.97 | $7.05 | $7.19 | 3 |
| 2027-03-27 | $2.82 | $2.86 | $2.91 | 4 |
| 2027-03-29 | $17.78 | $18.01 | $18.48 | 10 |
| 2027-06-27 | $4.43 | $4.49 | $4.57 | 7 |
| 2027-09-27 | $4.16 | $4.21 | $4.29 | 3 |
| 2027-12-27 | $7.23 | $7.31 | $7.45 | 4 |
| 2028-03-27 | $3.17 | $3.21 | $3.27 | 6 |
| 2028-03-29 | $19.37 | $19.94 | $20.91 | 5 |
| 2029-03-29 | $21.17 | $21.50 | $22.08 | 1 |
| 2030-03-29 | $23.24 | $23.61 | $24.25 | 1 |
Frequently Asked Questions
What is the analyst consensus for RL?
The consensus among 22 analysts covering Ralph Lauren Corporation (RL) is Buy with an average price target of $428.75.
What is the highest price target for RL?
The highest price target for RL is $435.00, set by Bob Drbul at BTIG on 2026-02-06.
What is the lowest price target for RL?
The lowest price target for RL is $102.00, set by Erinn Murphy at Piper Sandler on 2021-05-21.
How many analysts cover RL?
22 analysts have issued ratings for Ralph Lauren Corporation in the past 12 months.
Is RL a buy or sell right now?
Based on 22 analyst ratings, RL has a consensus rating of Buy (2.05/5) with a +17.9% upside to the consensus target of $428.75.
What are the earnings estimates for RL?
Analysts estimate RL will report EPS of $4.09 for the period ending 2026-06-27, with revenue estimated at $1.84B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.